Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet's Disease?

Autor: Alpaslan Mesci B; Department of Internal Medicine, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Işbilen Başok B; Department of Biochemistry, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Gül Sağun H; Department of Internal Medicine, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Gönenli G; Department of Internal Medicine, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Kavala M; Department of Dermatology, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Kasapoğlu Günal E; Department of Rheumatology, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Ekiz E; Department of Internal Medicine, Esenler Women's & Children Hospital, İstanbul, Turkey., Işman F; Department of Biochemistry, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey., Oğuz A; Department of Internal Medicine, Medeniyet University Göztepe Training and Research Hospital, İstanbul, Turkey.

Publikováno v: Archives of rheumatology [Arch Rheumatol] 2016 Dec 15; Vol. 32 (2), pp. 91-95. Date of Electronic Publication: 2016 Dec 15 (Print Publication: 2017).